Joint and Tendon Involvement Predict Severe Disease Progression in Systemic Sclerosis: A Prospective Study

Jérôme Avouac(Inserm), Yannick Allanore(Inserm), Paola Caramaschi(University of Verona), Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), L P Ananieva, P.E. Carreira, CP Denton(The Royal Free Hospital), U.A. Walker(Felix Platter-Hospital), Giovanna Cuomo(Regione Campania), Gabriela Riemekasten(Universitäres Kinderwunschzentrum Lübeck), Ulf Müller‐Ladner(Justus-Liebig-Universität Gießen), É. Hachulla(Centre Hospitalier Universitaire de Lille)
UCL Discovery (University College London)
October 1, 2014
Cited by 0

Related Papers

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
|Annals of the Rheumatic Diseases|2009|615